SCHEMBL5120782

SCHEMBL5120782

CCCCCCCCC(=O)NNC(=O)NC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.55
FAAH O00519 6/20 0.53
KMT2A Q03164 5/20 0.51
MAPT P10636 4/20 0.51
MEN1 O00255 3/20 0.51
KDM4E B2RXH2 1/20 0.51
MAPK1 P28482 1/20 0.50
GAA P10253 1/20 0.49
ALDH1A1 P00352 2/20 0.47
CES2 O00748 3/20 0.46
CES1 P23141 3/20 0.46
NPSR1 Q6W5P4 1/20 0.46
P2RX7 Q99572 1/20 0.45
GPR84 Q9NQS5 2/20 0.45
PPARG P37231 2/20 0.45
PPARD Q03181 2/20 0.45
PPARA Q07869 2/20 0.45
TSHR P16473 1/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
SLC22A8 Q8TCC7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5120466 1.00 HSP90AA1 (0.55) HSP90AA1FAAHKMT2AMAPTMEN1
SCHEMBL29380702 0.87 HSP90AA1 (0.70) HSP90AA1FAAHKMT2AMAPTMEN1
SCHEMBL6470717 0.87 HSP90AA1 (0.70) HSP90AA1FAAHKMT2AMAPTMEN1
SCHEMBL29380211 0.87 HSP90AA1 (0.70) HSP90AA1FAAHKMT2AMAPTMEN1
SCHEMBL7103156 0.87 HSP90AA1 (0.70) HSP90AA1FAAHKMT2AMAPTMEN1
SCHEMBL7108790 0.87 HSP90AA1 (0.70) HSP90AA1FAAHKMT2AMAPTMEN1
SCHEMBL9149574 0.87 HSP90AA1 (0.70) HSP90AA1FAAHKMT2AMAPTMEN1
SCHEMBL22960696 0.87 HSP90AA1 (0.70) HSP90AA1FAAHKMT2AMAPTMEN1
SCHEMBL8497574 0.87 HSP90AA1 (0.70) HSP90AA1FAAHKMT2AMAPTMEN1
SCHEMBL10456368 0.87 HSP90AA1 (0.70) HSP90AA1FAAHKMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161325-A1 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome ELAN PHARMACEUTICALS, INC. 2008-07-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161325-A1 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome BACE1, APP, BACE2 HSP90AA1 3589/4885FAAH 343/4885KMT2A 2573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.